Screening for leukemia- and clone-specific markers at birth in children with T-cell precursor ALL suggests a predominantly postnatal origin
Susanna Fischer(St Anna Children's Hospital), E. Renate Panzer-Grümayer(St Anna Children's Hospital), Georg Ebetsberger(Salzburger Landeskliniken), Oskar A. Haas(St Anna Children's Hospital), M Konrad(St Anna Children's Hospital), Georg Mann(St Anna Children's Hospital), Neil D. Jones(University of Salzburg), Klaus Schmitt(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Bertrand Nadel(Hôpital Necker-Enfants Malades), Olaf A. Bodamer(Broad Institute), Markus Metzler(Friedrich-Alexander-Universität Erlangen-Nürnberg)
Cited by 28
Related Papers
Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood
|The Lancet|1998|964
Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease
|New England Journal of Medicine|2019|823
Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy
|European Journal of Pediatrics|2007|535
A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A
|New England Journal of Medicine|2016|494